MoneyWorks4Me

Shilpa Medicare submits analyst meet intimation

14 May 2026 Evaluate
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shilpa Medicare has enclosed the schedule of Q4- FY26 Earnings Conference Call, which is to be held on Friday, May 22, 2025, at 16.00 hrs. A copy of this intimation is also being made available at: https://www.vbshilpa.com/investor-presentation.php

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..